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Abstract 
Gram-negative bacteria are equipped with quality control systems for the outer membrane (OM) 
that sense and cope with defective biogenesis of its components. Accumulation of misfolded 
outer membrane proteins (OMPs) in Escherichia coli leads to activation of σE, an essential 
alternative σ factor that upregulates transcription of multiple genes required to preserve OM 
structure and function. Disruption of bepA (formerly yfgC), a σE-regulated gene encoding a 
putative periplasmic metalloprotease, sensitizes cells to multiple drugs, suggesting that it may 
be involved in maintaining OM integrity. However, the specific function of BepA remains 
unclear. Here, we show that BepA enhances biogenesis of LptD, an essential OMP involved in 
OM transport and assembly of lipopolysaccharide, by promoting rearrangement of 
intramolecular disulfide bonds of LptD. In addition, BepA possesses protease activity and is 
responsible for the degradation of incorrectly folded LptD. In the absence of periplasmic 
chaperone SurA, BepA also promotes degradation of BamA, the central OMP subunit of the 
β-barrel assembly machinery (BAM) complex.  Interestingly, defective oxidative folding of 
LptD caused by bepA disruption was partially suppressed by expression of protease-active site 
mutants of BepA, suggesting that BepA functions independently of its protease activity. We 
also show that BepA has genetic and physical interaction with components of the BAM 
complex. These findings raised the possibility that BepA maintains the integrity of OM both by 
promoting assembly of OMPs and by proteolytically eliminating OMPs when their correct 
assembly was compromised.  
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Significance Statement 
Outer membrane proteins (OMPs) are involved in important cellular activities in gram-negative 
bacteria. Although the bepA (formerly yfgC) gene encoding a putative metalloprotease has been 
implicated in quality control of OMPs, its specific function remains unclear. This study reveals 
that BepA promotes assembly of LptD, an OMP involved in the transport of 
lipopolysaccharides, which undergoes intramolecular disulfide rearrangement during its 
biogenesis. BepA also promotes degradation of incorrectly folded LptD. BamA, another OMP 
involved in OMP assembly, is also degraded in a BepA-dependent manner in the absence of 
periplasmic chaperone SurA. BepA thus controls the quality of OMPs by promoting either the 
biogenesis or elimination of OMPs, depending on their folding state. 
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/body 
The cell envelope of gram-negative bacteria is composed of two layers of biological membranes, 
the outer membrane (OM) and the inner (cytoplasmic) membrane (IM); the periplasmic space 
that separates these membranes contains a thin layer of peptidoglycans. Outer membrane 
proteins (OMPs) span the OM with amphipathic, antiparallel β-strands that form a barrel 
structure. OMPs are synthesized in the cytoplasm with a cleavable signal peptide at their 
N-termini and are translocated across the IM through the Sec translocon (1). Signal 
peptide-processed OMPs are transported across the periplasmic space with the aid of 
periplasmic chaperones, such as SurA, Skp, and DegP, and are inserted into the OM through the 
function of the β-barrel assembly machinery (BAM) complex (2). The BAM complex is 
composed of five components: BamA, an essential OMP belonging to the Omp85 superfamily 
that includes the mitochondrial Sam50 and chloroplast Toc75 proteins, and four lipoprotein 
subunits (BamB-E) (3-6). BamD is essential for the growth of Escherichia coli, while the other 
three lipoprotein subunits are dispensable (5-7). BamA contains periplasmically exposed 
polypeptide transport-associated (POTRA) domains that bind the lipoprotein subunits of the 
BAM complex as well as substrate OMPs (8). 
LptD, another essential OMP of gram-negative bacteria, is involved in the assembly of 
lipopolysaccharide (LPS), a major OM constituent, in the OM (9). LPS is essential for the 
function of the OM as a permeability barrier. It is synthesized in the IM and targeted to the outer 
leaflet of the OM through the functions of seven Lpt proteins (LptA–G). LptBFGC and LptDE 
constitute IM and OM complexes, respectively, and LptA connects these two complexes by 
shuttling or forming a bridge between the two membranes (10-14). While LptD is involved in 
flipping of LPS from the periplasmic side to the outer side of the OM (9), LptE is thought to 
contribute to LPS transport through promotion of LptD folding (15). However, a recent view by 
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Kahne and colleagues suggested that LptE also directly contributes to LPS transport by serving 
as a “plug” for the lumenal pore of LptD and by acting as a part of the OM LPS translocon 
together with LptD (16, 17). LptD has two intramolecular disulfide bonds and requires DsbA, a 
periplasmic oxidoreductase, for its oxidative folding (18, 19). Recently, Chng et al. reported that 
LptD is assembled into the OM via formation of a folding intermediate containing non-native 
disulfide bonds that are finally isomerized to native disulfide bonds (17). Importantly, folding of 
the LptD β-barrel is rate-limiting for maturation of LptD and precedes disulfide isomerization, 
the step triggered by association with LptE. Analysis with a DsbA mutant that forms kinetically 
stable mixed-disulfide intermediates with substrates suggested that DsbA is involved in 
formation of both non-native and native disulfide bonds in LptD (17). A previous study also 
suggested that DsbC participates in the oxidative folding of LptD (17, 20), although disruption 
of the dsbC gene had little effect on the stability of LptD (19). 
Consistent with the vital roles of the cell envelope, E. coli is equipped with multiple 
envelope stress response systems to sense and cope with disorders of OM constituents (21). 
Among them, the σE-dependent stress response system is the only essential one and is probably 
one of the most important for the maintenance of the OM structure and function. Imbalanced 
biogenesis and/or defective assembly of OMPs and LPS leads to cytoplasmic activation of σE, 
an extracytoplasmic function σ factor responsible for the transcription of a class of genes 
involved in biogenesis and quality control of the OM components, including those for subunits 
of the BAM complex and LPS biosynthetic enzymes (22-24). 
To date, 114 genes have been identified as members of the E. coli σE regulon (24); 
however, their functions are not fully understood, making them a treasure trove for 
identification of novel regulators of OM integrity. The products of the σE-controlled genes 
included four periplasmic protease homologs, DegP, PtrA, YhiJ, and YfgC. DegP is a 
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protease/chaperone that can switch between these activities, thereby acting in both the assembly 
and elimination of OMPs (25-27). In contrast, functions of the other three protease homologs 
remain largely unknown. Recently, genome-wide comprehensive analyses of the antibiotic 
sensitivity of an E. coli single-gene knockout library showed that disruption of the yfgC gene 
renders cells sensitive to multiple drugs (28-31). Moreover, profiling of the chemical 
sensitivities of ΔyfgC cells has suggested that this putative protease is involved in the biogenesis 
and/or quality control of OMPs (31). The amino acid sequence of YfgC indicates that it belongs 
to the peptidase M48 family and possesses a typical zinc metalloproteinase active site motif, 
H136EXXH. In addition, the C-terminal portion of YfgC contains 4 copies of the 
tetratricopeptide repeat (TPR) motif, a structural element involved in protein-protein 
interactions (32). Members of the M48 family include mitochondrial Oma1 (33), Ste24p (34), 
and E. coli HtpX (35). HtpX is a membrane-anchored protease with its protease-active site 
exposed to the cytoplasm and is thought to collaborate with the AAA+ protease FtsH to 
eliminate misfolded IM proteins (36). YfgC has recently been reported to interact with and 
contribute to proper localization of LoiP (YggG), an OM-associated protease homologous to 
YfgC (37). However, the proteolytic activity of YfgC has not been demonstrated, and its 
specific cellular function remains obscure.  
In this study, we sought to determine the molecular functions of YfgC in maintaining 
the structure and function of the cell envelope. Our results suggest that YfgC exerts dual 
functions, promoting either the biogenesis or proteolytic elimination of OMPs, depending on the 
folding state of the OMPs. Therefore, we suggest that YfgC should be renamed as BepA 
(β-barrel assembly-enhancing protease). 
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Results 
BepA processes a protease activity that is important for maintenance of the OM integrity. 
While BepA carries a conserved zinc metalloprotease active site motif, H136EXXH, it is not 
known whether BepA possesses a protease activity. To verify whether BepA is indeed a 
protease, we purified C-terminally decahistidine (His10)-tagged wild-type BepA (BepAHis10) and 
its derivative with an amino-acid substitution (E137Q) in the metalloprotease active site motif 
by metal affinity chromatography. Incubation of α-casein, a model substrate, with wild-type 
BepAHis10 gave rise to a small but significant amount of a band that migrated slightly faster than 
α-casein (Fig. 1A, open arrowhead). The N-terminal sequence of this band turned out to be 
FVAPF that matches the 24th to 28th residues of α-casein, indicating that it was generated by 
cleavage between F23-F24. Generation of this fragment was inhibited when metal chelating 
reagent 1,10-phenanthroline or EDTA was included in the reaction mixture (Fig. 1B). 
Furthermore, incubation of α-casein with the protease active site motif mutant, 
BepA(E137Q)His10, did not produce such a fragment (Fig. 1A). Although the observed in vitro 
proteolytic activity of BepA is rather low for unknown reasons, the above results collectively 
demonstrate that BepA is indeed a metalloprotease.  
Disruption of the bepA gene causes significantly elevated sensitivity to high-molecular 
mass antibiotics, such as erythromycin and vancomycin (28-31; Fig. 1C), indicating that loss of 
BepA compromises the function of OM as a permeability barrier. We examined the 
complementation activities of two active site motif mutants, BepA(E137Q) and BepA(H136R), 
against the ΔbepA mutation. In contrast to wild-type BepA, these mutants failed to restore drug 
resistance to the ΔbepA mutant (Fig. 1C), although they accumulated at levels comparable to the 
wild-type protein (Fig. 1D). Importantly, these protease-dead mutants exhibited a 
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dominant-negative phenotype, as their expression in the wild-type (bepA+) strain significantly 
increased sensitivity to erythromycin (Fig. 1C). It is not unexpected that proteases with a 
compromised proteolytic active site can exhibit a dominant-negative phenotype since they often 
retain other activities (e.g., substrate binding, oligomerization) and thus compete with the 
wild-type protein. These results suggest that protease activity of BepA is important for its 
function to maintain OM integrity. Indeed, as described in later sections (see Fig. 5 and 8), our 
results demonstrate that BepA is involved in degradation of misfolded OMPs. 
Isolation of multicopy suppressors of the bepA-null mutation. Despite apparent dysfunction 
of OM, disruption of bepA gene has little impact on the profiles of OMPs and heat modifiability 
of a major OMP, OmpA (Fig. S1). To gain insight into the role of BepA in the envelope 
function, we sought multicopy suppressors of the ΔbepA mutation. Multicopy suppressors 
provide clues to important functions of a deleted gene by identifying alternative routes to 
performing the key function disabled by the gene deletion. While the ΔbepA strain was sensitive 
to erythromycin, the ΔbamE/ΔbepA strain showed greater sensitivity to multiple drugs than the 
bepA deletion alone (see Fig. 6A and B). We thus used the double-mutant strain as the basis for 
the multicopy suppressor screen. For this screen, we used the ASKA clone library of 4,123 E. 
coli open reading frames (ORFs), individually cloned under the isopropyl-thio-β-D 
-galactopyranoside (IPTG) -inducible promoter of a chloramphenicol-resistant multicopy vector 
(38). Pools of ASKA clones were introduced into the ΔbamE/ΔbepA strain, and transformants 
were selected on agar plates containing 20 µg/mL chloramphenicol and 5 µg/mL erythromycin, 
with (100 µM) or without IPTG to induce the cloned genes. Both regimes were utilized because 
high expression can sometimes be toxic. Among the ASKA pools, we found 9 
erythromycin-resistant transformants without IPTG, and 248 transformants with IPTG. After 
verifying that drug resistance was linked to each plasmid (by retransformation with plasmids 
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isolated from the first isolated drug-resistant bacteria), cloned genes were identified by DNA 
sequencing. We then tested whether these multicopy suppressors conferred resistance to other 
ΔbamE/ΔbepA-derived drug sensitivities (e.g., SDS and vancomycin; Table S1) and retained the 
14 clones that conferred resistance to all of the selection reagents. Of these, only the clone 
carrying lptE conferred erythromycin and vancomycin resistance to a level comparable to a 
plasmid carrying wild-type bepA, even in the absence of IPTG (Fig. 2A and Table S1). 
Furthermore, when lptE was under tight arabinose control, the erythromycin sensitivity of the 
ΔbepA strain was suppressed in an arabinose-dependent manner (Fig. 2B). These results 
established that overexpression of LptE compensated for the lack of BepA, at least with respect 
to the drug-sensitive phenotypes examined. LptE/D form the essential OM translocon that is 
required for export of LPS to the outer leaflet of the OM (9, 10, 16), and LptE assists the 
biogenesis and/or function of LptD (10, 15-17), suggesting that BepA may participate in the 
formation of functional LptD. 
LptD with non-native disulfide bonds accumulates in the absence of BepA. LptE promotes 
the proper oxidation of LptD and stabilizes LptD protein (19, 39). It seemed thus possible that 
lack of BepA, like that of LptE, destabilizes LptD. Also, considering that drug sensitivity of the 
ΔbepA strain was suppressed by overproduction of LptE, it might be also possible that the bepA 
disruption might cause decrease in the LptE level. However, these were ruled out, as the levels 
of LptD and LptE were little affected by the presence or absence of BepA (Fig. 3A, + ME). We 
next considered whether BepA affected disulfide bond formation in LptD. Mature LptD has two 
intramolecular disulfide bonds between nonconsecutive pairs of Cys residues (C31-C724 and 
C173-C725; mature LptD with correct disulfide bonds referred to here as LptDNC) (19). As 
reported previously (19), correctly disulfide-bonded LptDNC migrates more slowly than the fully 
reduced form (Fig. 3A, - ME, left lane). Importantly, the ΔbepA strain had an additional band 
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(LptDC) that migrated more rapidly than the fully reduced band (Fig. 3A, - ME, right lane). 
To unambiguously establish that different disulfide bond connectivity was responsible 
for generation of LptDC, we examined the migration patterns of C-terminally hexahistidine 
(His6)-tagged LptD proteins (LptDHis6) having various combinations of their four Cys residues 
changed to Ser, thereby restricting which disulfide bonds were able to form. LptD(CCSS)His6, 
which formed only the sequential C31-C173 disulfide bond, gave only the rapidly migrating 
species, even in the wild-type (bepA+) strain (Fig. S2A). In contrast, LptD(SSCC)His6, which 
formed only the sequential C724-C725 disulfide-bond, did not produce this rapidly migrating 
species. As reported (17), the C724-C725 disulfide bond can actually be formed, as this species 
was nonreactive with the sulfhydryl-reactive alkylating reagent, maleimide PEG2-biotin, unless 
it had been reduced with DTT before the alkylating reaction (Fig. S2B). All species that could 
form the C31-C173 bond (CCCC, CCSC, and CCCS) promoted LptDC formation in the absence of 
BepA (Fig. S2A). We thus concluded that LptDC had non-native disulfide bonds, at least 
between C31 and C173 and possibly between C724 and C725 (Fig. 3B). Subcellular fractionation 
revealed that, like LptDNC, LptDC was associated with the OM (Fig. S2C and D). 
BepA promotes formation of the proper intramolecular disulfide bonds in LptD. It has 
been recently reported that LptD is assembled into the OM via formation of an intermediate 
containing non-native disulfide bonds linked between consecutive Cys residues that are 
isomerized to native disulfide bonds, the step triggered by assembly with LptE (17). Our results 
suggest that LptDC corresponds to the folding intermediate with consecutive disulfide bonds and 
the absence of BepA causes its accumulation. To determine whether LptDC is indeed an 
on-pathway species, we examined the kinetics of formation of LptDNC and LptDC by 
pulse-labeling cells with [35S]-methionine for 1 min, followed by chase with excess non-labeled 
methionine. In wild-type cells, almost all labeled LptD molecules were present as LptDC after a 
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1-min chase and were then converted to LptDNC in a process in which an initial rapid (t1/2 ~10 
min) phase was followed by a slower conversion that took approximately 40 min for completion 
(Fig. 4A). Like in wild-type cells, LptD was mostly detected as LptDC after a 1-min chase in 
ΔbepA cells and was converted to LptDNC upon chase. However, this conversion took a much 
longer time (t1/2 > 80 min; Fig. 4A) in ΔbepA cells. Conversely, the rate of LptDC to LptDNC 
conversion was restored by overproduction of BepA in ΔbepA cells (Fig. 4B). The conversion 
was slightly but significantly accelerated by overproduction of BepA, even in wild-type cells 
(Fig. S3). These results indicate that BepA promotes disulfide isomerization of LptD and that 
the process promoted by BepA is rate-limiting for LptD maturation. Importantly, 
overexpression of LptE in ΔbepA cells promoted both the extent and rate of the conversion of 
LptD to approximately those of wild-type cells (Fig. S4), suggesting that the suppression of 
ΔbepA by LptE overexpression resulted mainly from restoration of LptDNC formation. 
We found that ectopic expression of the H136R or E137Q mutant of BepA in ΔbepA 
cells also promoted LptDC to LptDNC conversion, albeit less effectively than wild-type BepA 
(Fig. 4B). In contrast, these mutants slightly retarded this conversion process when expressed in 
wild-type (bepA+) cells (Fig. S3), which was consistent with their dominant-negative properties. 
These results indicated that BepA could promote oxidative folding of LptD independently of its 
protease activity, although the intact protease motif is still required for its full functioning. 
Disulfide isomerization of periplasmic and OM proteins is mainly catalyzed by DsbC 
(18), but that of LptD proceeds even in the absence of DsbC (17; Fig. S5A). Additional 
disruption of the dsbG gene, encoding possible periplasmic disulfide isomerase, had essentially 
no effect (Fig. S5A). Therefore, DsbC and DsbG may be dispensable for disulfide exchange in 
the process of LptD biogenesis. The oxidoreductase DsbA is required for the oxidative folding 
of LptD (17, 18). In the absence of DsbA, several bands, including both LptDC and LptDNC, 
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were generated after a 1-min chase (Fig. S5B). When treated with a reducing reagent, they were 
converted to LptDRED (Fig. S5B), indicating that they were LptD species with different oxidative 
states. These results suggested that, in the absence of DsbA, both consecutive and 
nonconsecutive disulfide bonds were formed stochastically. 
BepA degrades LptD when LptD fails to form the OM LPS translocon. In agreement with 
the recent reports by Chng et al. (17), we found that the LptDC to LptDNC conversion was almost 
completely blocked in LptE-depleted cells (Fig. 5A). In addition, the pulse-chase experiment 
revealed that LptDC was significantly destabilized in this condition (Fig. 5A). Strikingly, LptDC 
became stable, even under LptE-limiting conditions, when bepA was disrupted (Fig. 5A), and 
the LptDC-stabilizing effect of ΔbepA was suppressed by expression of wild-type but not 
protease-dead BepA protein from a plasmid (Fig. 5B). Furthermore, ectopic expression of 
wild-type BepA led to increased destabilization of LptDC in LptE-depleted cells carrying 
chromosomal bepA+, whereas that of protease-dead BepA mutants dominantly stabilized LptDC 
(Fig. 5C). These results strongly suggest that BepA functions as a protease in vivo to degrade 
LptD that has failed to interact with LptE to form the functional LPS translocon. 
Genetic interaction of bepA with bamB and bamE. The ΔbepA strain exhibits elevated drug 
sensitivity (28-31; Fig. 1C), a phenotype reminiscent of deletion of some of the nonessential 
members (bamB, bamC, and bamE) of the BAM complex (31). The BAM complex, composed 
of one β-barreled subunit (BamA) and four lipoprotein subunits (BamB–E), facilitates insertion 
of β-barrel proteins into the OM. The similarities in the antibiotic sensitivity phenotypes of 
these proteins suggested that BepA may have some functional interaction with the Bam 
components. Consistent with this idea, ΔbamB/ΔbepA or ΔbamE/ΔbepA double mutants 
displayed elevated sensitivity toward multiple antibiotics (Fig. 6A). These double mutants also 
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exhibited significantly higher SDS sensitivity; they grew much more slowly than the wild-type 
cells in the presence of 0.5% SDS, although the viability of cells seemed almost the same (Fig. 
6B). None of the single mutations conferred these phenotypes (Fig. 6B). These results show that 
bepA genetically interacts with bamB and bamE. Interestingly, the protease-dead BepA mutant 
proteins restored the SDS resistance of the ΔbamB/ΔbepA strain at 30°C, supporting the above 
notion that BepA plays a nonproteolytic role (Fig. 6C), while they failed to restore the SDS 
sensitivity of the ΔbamE/ΔbepA strain. Moreover, these mutant proteins dominantly sensitized 
the ΔbamE/ΔbepA cells to SDS at 37°C, underscoring the fact that the residual activity of 
protease-defective proteins could be deleterious to the cell (Fig. 6C). 
BepA is localized in close proximity to the BAM complex. We then investigated possible 
physical interaction with envelope components, such as the BAM complex. The SOSUI 
program (40) predicted BepA to be a periplasmic protein with an N-terminal 27 amino 
acid-long signal peptide. As expected, upon cell fractionation, BepA was predominantly 
recovered in the soluble fraction (Fig. S6). However, a significant amount of BepA was also 
present in the membrane fraction (Fig. S6). As an unbiased approach to identify putative BepA 
binding partners, we used chemical cross-linking. Wild-type cells with a plasmid encoding 
C-terminally His10-tagged BepA (BepAHis10) or its H136R or E137Q derivatives were converted 
to spheroplasts and treated with bis(sulfosuccinimidyl) suberate (BS3), a 
membrane-impermeable and amine-reactive cross-linker, and analyzed by SDS-PAGE and 
anti-BepA immunoblotting (Fig. 7A). BepAHis10 gave rise to several cross-linked products (Fig. 
7A), which were even more obvious with BepA(H136R)His10 and BepA(E137Q)His10. Enhanced 
cross-linking with protease-dead mutants may be attributable to stalling reactions caused by 
impaired protease activity. Metal affinity chromatography followed by liquid 
chromatography-mass spectrometry analysis of the strongest cross-linked band of 
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BepA(E137Q)His10 (~170 kDa) identified BamA, the central subunit of the BAM complex (Fig. 
S7). Immunoblotting with anti-BamA antibodies confirmed BamA-BepA cross-linking (Fig. 
7B). As expected, BamA-BepA adducts were almost exclusively recovered in the membrane 
fraction (Fig. 7B). To examine the possible interaction of BepA with other subunits of the BAM 
complex, we compared the patterns of BS3-mediated adduct production in the presence or 
absence of the nonessential lipoprotein subunits, i.e., BamB, BamC, or BamE. In addition to the 
BamA-BepA(E137Q) adduct detected in all strains (Fig. 7C and D), a cross-linked product of 
~110 kDa, reactive with both anti-BepA and anti-BamC antisera, was detected in wild-type, 
ΔbamB, and ΔbamE strains, but not in the ΔbamC strain (Fig. 7C and F). Additionally, an 
~85-kDa band reactive with both anti-BepA and anti-BamD antisera was detected in the ΔbamC 
strain (Fig. 7C and G). No cross-link between BepA and BamB was observed (Fig. 7E).  
As an alternative approach to probe possible interaction, we carried out site-directed in 
vivo cross-linking experiments. The C-terminal portion of BepA contains four copies of the 
TPR motif, which is widely involved in protein-protein interactions. We expected that the BepA 
TPR motifs would participate in interaction with other proteins and substituted an amber codon 
for the Q428 codon in the fourth TPR motif of BepA, to allow suppressor tRNA-mediated 
introduction of a non-natural, photo-reactive amino acid, p-benzoylphenylalanine (pBPA), at 
this position (41). Cells expressing BepA(Q428pBPA) were UV-irradiated and analyzed by 
SDS-PAGE and immunoblotting. We found that a band of about 135 kDa that was reactive with 
both anti-BepA and anti-BamA antibodies was yielded in UV-irradiation and pBPA-dependent 
manners (Fig. 7H), indicating that it represents a BamA-BepA(Q428pBPA) adduct.  
The BAM complex is rather stable, enabling purification of the entire BAM complex 
using a polyhisitidine tag attached to a BAM component (6, 42). To examine whether formation 
of the cross-linked adducts reflects direct interaction between BepA and the BAM complex, 
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BepA(E137Q) was co-expressed with C-terminally His6-tagged BamB (BamBHis6) in the 
ΔbamB strain. Metal affinity chromatography followed by SDS-PAGE and immunoblotting 
revealed that, along with other Bam components, a portion of BepA(E137Q) was co-isolated 
with BamBHis6 (Fig. 7I). Taken together, these results strongly suggest that BepA directly 
interact with the BAM complex possibly via its TPR domain. Its membrane localization could 
be at least partly resulted from this interaction. 
BepA cleaves BamA in cells lacking SurA. The above finding that BepA interacts with BamA 
prompted us to examine the possibility that BamA becomes a proteolytic substrate of BepA. In 
the wild-type background, however, we detected no difference in the profiles of 
anti-BamA-reactive bands between wild-type and ΔbepA strains (Fig. 8, upper panel, lanes 1 
and 2). We next compared the profiles of anti-BamA-reactive bands in the ΔsurA background. 
SurA is thought to play a primary role in the biogenesis of OMPs, and disruption of the surA 
gene causes massive decreases in the levels of OMPs and increased permeability to a wide 
variety of drugs (43). Absence of SurA does not affect β-barrel folding of BamA in cells grown 
in rich media (44). However, we detected several anti-BamA-reactive bands that were smaller 
than intact BamA in ΔsurA cells when the cells were grown in minimal media. These bands 
were hardly detected in ΔsurA/ΔbepA double mutants (Fig. 8, upper panel, lanes 3 and 4) but 
regenerated upon ectopic expression of wild-type but not protease-dead BepA proteins (Fig. 8, 
upper panel, lanes 5–8) in the same strain background, suggesting that they are BamA 
degradation products. Degradation of other OMPs such as LamB and OmpA was not observed 
(Fig. S8A and B) under similar conditions. Loss of SurA could induce the σE stress response and 
cause upregulation of BepA. However, BamA degradation observed in the ΔsurA strain was not 
the direct results of increased synthesis of BepA, because overexpression of BepA in the surA+ 
strain did not cause BamA degradation (Fig. S8C). It is unclear why BamA degradation 
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products were not detected in cells grown in rich media, but they may be further degraded by 
other proteases in that case. Collectively, these results suggest that proper assembly of BamA is 
compromised in the absence of SurA and that BepA degrades BamA under such a condition. 
Alternatively, as BamA has been suggested to assume different conformations during its 
functional cycle (45, 46), the absence of SurA might cause accumulation of the 
BepA-susceptible form of BamA. 
 We noticed that C-terminally His10-tagged wild-type BepA migrated faster than its 
H136R or E137Q derivative and migrated slightly slower than chromosomally-encoded BepA 
upon SDS-PAGE (Fig. 8, lower panel). It seems likely that BepAHis10 underwent self-cleavage 
within its C-terminally attached tag sequence, which further supports our result that BepA 
possesses proteolytic activity.  
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Discussion 
In this study, we investigated the cellular functions of BepA, a σE-regulated, periplasmic 
protease homolog implicated in the maintenance of OM integrity. With a purified preparation, 
we demonstrated that BepA indeed possesses a proteolytic activity. Our genetic and 
biochemical analyses suggest that BepA acts in the assembly/degradation of two essential 
OMPs, LptD and BamA, the central components of OM translocons for LPS and OMPs, 
respectively. Importantly, we showed that BepA can promote disulfide isomerization of LptD 
independently of its protease activity and degradation of LptD and BamA when their proper 
assembly is compromised. Our results suggest that BepA acts as a protease/chaperone that 
contributes to OM quality control by directly and/or indirectly affecting biogenesis of both 
OMPs and LPS. 
BepA promotes maturation of LptD. LptD is converted into the mature form with 
nonconsecutive disulfide bonds (LptDNC) via an intermediate with non-native, consecutive 
disulfide bonds (LptDC) (17). While Chng et al. identified this intermediate using 
epitope-tagged LptD expressed from a plasmid (17), we showed that chromosomally encoded 
LptD also follows this assembly pathway. A detailed study by Kadokura and Beckwith 
suggested that while disulfide bonds of proteins are formed vectorially from the N-terminus to 
the C-terminus in the periplasm when the protein is cotranslationally translocated across the IM, 
post-translationally translocated proteins have more relaxed restrictions for the order of 
disulfide bond formation (47). Although LptD is presumably exported across the membrane 
post-translationally, disulfide bonds are exclusively formed in the N-to-C order. The finding 
that the precursor form of LptD, observed after 1-min chase, migrated more rapidly in 
nonreducing SDS-PAGE than in reducing gels (Fig. 4A) supports that at least the disulfide bond 
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between C31 and C173 can be formed before completion of polypeptide translocation. The 
physical distance between the two Cys pairs (separated by 550 amino acids) may contribute to 
the exclusive formation of LptDC, even in a post-translational translocation pathway. DsbA is 
involved in the oxidative folding pathway of LptD (17-19) and disulfide bonds of LptD are 
formed stochastically in the absence of DsbA. Oxidants in the media or molecular oxygen may 
contribute to oxidizing some populations of LptDRED directly to LptDNC, as previously 
suggested (19), which may be why DsbA is non-essential even though it appears to have critical 
roles in the biogenesis of essential LptD. 
We screened for multicopy suppressors against the drug sensitivity phenotype of the 
ΔbepA strain and identified the lptE gene that encodes a protein involved in the function and/or 
folding of LptD (15). This suggests that BepA is also involved in LptD biogenesis. In agreement 
with this notion, we found that disruption of bepA delayed the rearrangement of LptD disulfide 
bonds, causing accumulation of LptDC, which was suppressed by overexpression of LptE. 
Disulfide bond rearrangement in LptD is triggered by its association with LptE (17). Our 
finding of suppression by LptE overproduction of defective LptDC-to-LptDNC conversion due to 
loss of BepA suggests that BepA promotes LptD/E association. Through the isolation and 
analyses of mutations in bamA that allele-specifically suppress an lptE mutation, it was 
proposed that LptE interacts with LptD that is being assembled by the BAM complex (15). 
BepA may directly assist efficient interaction between LptD and LptE at the BAM complex or 
act at some other step during LptD assembly to eventually facilitate formation of a productive 
LptD/E complex (Fig. 9, upper panel). 
Possible dual functions of BepA as a chaperone and protease. Here, we purified BepA and 
showed that it has a low but significant protease activity against α-casein. Its protease activity 
was inhibited by metal chelating reagents or amino acid substitution in the putative protease 
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active-site motif (HEXXH), suggesting that BepA is a metalloprotease as deduced from its 
sequence homology to the M48 family of zinc metalloproteinases. Protease-dead BepA mutants 
are defective in complementation of the ΔbepA mutation and exert dominant-negative effects 
when expressed in wild-type (bepA+) cells. Degradation of LptDC in LptE-depleted cells and 
BamA in ΔsurA cells was dependent on BepA with an intact protease active-site motif. 
Moreover, overexpression of wild-type BepA accelerated degradation of LptDC in 
LptE-depleted cells, whereas protease-dead BepA mutants dominantly stabilized LptDC under 
the same conditions. Our observations collectively suggest that BepA directly proteolyzes 
OMPs such as LptD and BamA in vivo and that protease activity is important for its function in 
maintaining OM integrity (Fig. 9, lower panel). Although the observed in vitro protease activity 
was quite modest, it might be improved by, for instance, optimization of the assay conditions 
and/or addition of unidentified partner proteins. 
Several lines of evidence suggest that BepA also possesses a protease 
activity-independent function. We found that the SDS sensitivity of the bamB/bepA double 
disruptant was complemented by protease-dead mutants. Disulfide rearrangement of LptD was 
also promoted by these protease-dead BepA derivatives. Furthermore, overexpression of BepA 
in wild-type cells facilitated the rate of LptDC to LptDNC conversion (Fig. S3) without affecting 
the stability of LptD. It is thus conceivable that BepA can facilitate formation of the proper 
conformation of LptD independently of its protease activity. These characteristics of BepA are 
reminiscent of DegP, another σE-regulated protease that reversibly switches between a protease 
and a chaperone in a temperature- and substrate-dependent manner (25, 27). Our results suggest 
that BepA is able to function in two ways depending on the folding state of a substrate OMP: as 
a chaperone promoting the biogenesis of a substrate OMP or as a protease degrading it when it 
fails to assemble correctly into the OM. 
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It should be noted that rate of LptDC to LptDNC conversion was not fully restored by 
the expression of protease-dead BepA mutants in the ΔbepA strain; the protease-dead mutants 
effectively recovered the initial rate of LptDC to LptDNC conversion, but the final yield of 
LptDNC in protease-dead BepA-expressing cells was much lower than that in the strain 
expressing wild-type BepA. Although the exact reason for the above observations is unclear, a 
fraction of LptDC may elude the protease-dead mutants having reduced or altered chaperon-like 
activity and enter an off-target pathway after a certain period of time to yield a dead-end product 
that resists the action of BepA. The protease activity of BepA may also be required for its 
maximum activity to remove a portion of LptDC that would misfold, even in the presence of 
LptE, and competitively inhibit the function of BepA. 
BepA is involved in maintenance of OM integrity. bepA mutants exhibit hypersensitivity to a 
variety of hydrophobic and high-molecular-mass drugs. Recent large-scale chemical genomics 
combined with quantitative fitness measurements have suggested that the function of the bepA 
gene is highly correlated with those of genes involved in OMP and LPS biosynthesis (30, 31). 
Consistent with the above suggestion, our in vivo observation that additional disruption of the 
bamB or bamE gene synergistically elevated the SDS and antibiotic sensitivity of the ΔbepA 
strain suggested that BepA has genetic interactions with these BAM components and thus is 
involved in normal OM assembly. Direct interaction between BepA and the BAM complex was 
suggested from our biochemical results demonstrating that BepA can be pulled down with the 
BAM complex and cross-linked with BamA, BamC, and BamD. Site-specific in vivo 
photo-crosslinking experiments suggested that the TPR domain of BepA is involved in the 
interaction with BamA. These observations raise the possibility that BepA acts in cooperation 
with the BAM complex. 
Suppression of the antibiotic hypersensitivity of the ΔbepA strain by overexpression of 
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LptE, which would specifically improve the folding/assembly of LptD, suggests that the 
antibiotic hypersensitivity of this strain is mainly attributable to folding defects in LptD. 
Inefficient assembly of LptD would result in delay of LPS translocation across the OM, which 
causes phospholipids to flip from the inner to the outer leaflet of the OM (48). Impaired lipid 
asymmetry would then abolish the barrier function of OM against drugs. However, BepA may 
play a more general role in the biogenesis/quality control of OMPs. Synthetic lethal or sick 
phenotypes are often observed following disruption of two genes that have overlapping or 
compensatory functions. Indeed, we found that simultaneous disruption of bepA together with 
either bamB or bamE synthetically sensitized cells to SDS. In addition, BepA can interact with 
the BAM complex. The genetic and physical interactions between BepA and the BAM complex 
raise the possibility that BepA promotes the correct assembly of not only LptD but also other 
OMPs. The surA/bepA double disruptant was recently reported to exhibit a 
temperature-sensitive growth phenotype (49). Lack of SurA would produce misfolded BamA 
that could be normally eliminated by BepA, and the growth defects of the surA/bepA double 
disruptant may result from dysfunction of the BAM complex to assemble OMPs. Because lack 
of BepA does not cause a drastic change in β-barrel folding of OMPs that can be assessed by the 
heat-modifiability assay, it is not easy to assay maturation for most OMPs other than LptD, 
maturation of which can be assayed by examining the disulfide rearrangement. Improvement of 
experimental techniques to monitor folding/assembly states of OMPs would be required to test 
this possibility.  
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Materials and Methods 
Bacterial strains, plasmids, and media. The bacterial strains, plasmids and primers used in 
this study are listed in Table S2-S4. Their constructions are described in the Supporting 
Information. E. coli K12 strains AD16 (50), MC4100 (51), and AM604 (10) were used as 
wild-type strains. AM604 and GC187 (ParalptE) were a generous gift from Dr. Thomas J. 
Silhavy at Princeton University (Princeton, NJ). SM4106 (ΔbamB::tet) was a generous gift from 
Dr. Shin-ichi Matsuyama at Rikkyo University (Tokyo, Japan). KRX (Promega) and TOP10 
(Invitrogen) were used as hosts for protein expression and routine cloning procedures, 
respectively. The Keio collection (52), the ASKA library (38), and plasmid pCP20 were 
provided by the National BioResource Project-E. coli (National Institute of Genetics, Mishima, 
Japan). pEVOL-pBpF was purchased from Addgene (Cambridge, MA). Cells were grown in L 
medium (containing 10 g/L bactotryptone, 5 g/L yeast extract, and 5 g/L NaCl; the pH was 
adjusted to 7.2 by NaOH) or M9 medium (53) (with omission of CaCl2), supplemented with 
ampicillin and chloramphenicol at 50 and 20 µg/mL, respectively, when appropriate. 
Selection of multicopy suppressors. A total of 4,123 clones from the ASKA library were 
divided into 112 groups such that each group contained up to 48 clones. Mixtures of plasmids 
were prepared from each group and used to transform SN537 (ΔbepA ΔbamE). Transformants 
were selected at 30°C on L agar containing 20 µg/mL chloramphenicol and 0 or 5 µg/mL 
erythromycin in the presence or absence of 100 µM IPTG. Each group yielded 0–14 
erythromycin/chloramphenicol-resistant colonies, while 100–300 transformants were obtained 
on plates containing chloramphenicol but not erythromycin. Plasmids were purified from 
erythromycin/chloramphenicol-resistant colonies and reintroduced into SN537 to check whether 
erythromycin resistance was linked to each plasmid. The verified plasmid clones were 
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sequenced to identify the cloned genes. 
Pulse-chase and immunoprecipitation experiments. AD16, GC187, and their derivatives 
were grown to an early log phase in M9 medium supplemented with 19 amino acids other than 
methionine, 2 µg/mL thiamine, and 0.2% glucose at 30 or 37°C. Cells carrying a pTH18cr 
derivative were grown similarly, but in the presence of 0.2% maltose and 1 mM IPTG instead of 
glucose. Cells were labeled with 370 kBq/mL [35S]-methionine (American Radiolabeled 
Chemicals) for 1 min at 30 or 37°C, and chase was initiated by the addition of 0.04% (final 
conc.) nonradioactive methionine. Aliquots were withdrawn after 1, 2, 5, 10, 20, 40, 60, and 80 
min, and proteins were precipitated with trichloroacetic acid. Protein precipitates were dissolved 
in 50 mM Tris-HCl (pH 8.1) containing 1% SDS and 1 mM EDTA, boiled for 5 min, and 
diluted 20-fold with 50 mM Tris-HCl (pH 8.1) containing 150 mM NaCl, 2% Triton X-100, and 
0.1 mM EDTA. After removal of insoluble materials by centrifugation at 20,000 × g for 5 min, 
the supernatant was subjected to immunoprecipitation with anti-LptD antiserum and Dynabeads 
Protein A (Invitrogen). Immunoprecipitated proteins were eluted from beads by boiling for 5 
min in SDS-PAGE sample buffer with or without 1% 2-mercaptoethanol and were analyzed by 
SDS-PAGE and phosphorimaging with BAS-1500 (Fujifilm, Tokyo, Japan). Band intensities 
were quantified with MultiGauge software (Fujifilm). 
BS3-mediated cross-linking. MC4100 derivatives transformed with plasmids that encode BepA 
derivatives were grown to a late log phase at 30 or 37°C in L medium. Cells were harvested, 
washed once with buffer A (20 mM sodium-phosphate buffer [pH 7.2] containing 300 mM 
sucrose), and resuspended in the same buffer. After addition of 40 µg/mL lysozyme, cells were 
converted to spheroplasts by incubation at 4°C in buffer A containing 1 mM EDTA in the 
presence or absence of 1 mM BS3 (Thermo Fisher Scientific) for 30 min. Then, samples were 
 24 
separated into periplasmic and spheroplast fractions by centrifugation at 20,000 × g for 2 min. 
Spheroplasts were suspended in 50 mM Tris-HCl (pH 7.5) and disrupted by sonication. After 
removal of unbroken cells by centrifugation at 10,000 × g for 2 min, membranes were collected 
by ultracentrifugation at 100,000 × g for 30 min. Proteins in the periplasmic and membrane 
fractions were precipitated by the addition of 10% (final conc.) trichloroacetic acid and were 
subjected to SDS-PAGE and immunoblotting. 
pBPA-mediated photo-crosslinking. SN56 transformed with pUC-BepA(Q428Amber) and 
pEVOL-pBpF was grown at 30°C to a late log phase in L medium supplemented with 0.2% 
arabinose and 1 mM IPTG in the presence or absence of 1 mM pBPA (Bachem, Bubendorf, 
Switzerland). Cells were chilled on ice for 10 min and UV-irradiated at 365 nm on a Petri dish 
for 10 min by using a B-100AP UV lamp (Ultraviolet Products, Upland, CA) at a distance of 4 
cm. Cells were then harvested, suspended in 20 mM Tris-HCl (pH 7.5) and disrupted by 
sonication. After removal of unbroken cells by centrifugation at 10,000 × g for 2 min, 
membranes were collected by ultracentrifugation at 100,000 × g for 30 min. Proteins in the 
membrane fractions were precipitated by trichloroacetic acid and subjected to SDS-PAGE 
followed by immunoblotting.  
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Figure legends 
Fig. 1. Protease activity is required for BepA function. (A) Protease activity of BepA. α-casein 
(400 µg/mL) was incubated without (-) or with His10-tagged wild-type BepA (WT) or its E137Q 
derivative (E137Q) (200 µg/mL) at 37°C for 0 or 24 h. Proteins were separated by SDS-PAGE 
and visualized by staining with Coomassie brilliant blue R-250. Proteolytic product of α-casein 
is indicated by an open arrowhead. Migration positions of molecular weight markers are shown 
on the left. (B) Effects of metal chelators on the BepA protease activity. Protease activity of 
C-terminally His10-tagged wild-type BepA was analyzed as in A except that the reaction mixture 
contained 50 µM ZnCl2 (Zn), 250 µM 1,10-Phenanthroline (PT), or 250 µM EDTA. (C) 
Erythromycin sensitivity of cells expressing BepA or its derivative. The minimum inhibitory 
concentration (MIC) of erythromycin for the ΔbepA or wild-type strain transformed with 
pUC18 vector, pUC-bepA, pUC-bepA(H136R), or pUC-bepA(E137Q) encoding wild-type, 
H136R mutant, or E137Q mutant BepA, respectively, at 30°C are shown. (D) Cellular levels of 
BepA. BepA levels in the ΔbepA cells used in (C) were determined by immunoblotting with 
anti-BepA antiserum. Maltose-binding protein (MBP) was also detected by immunoblotting 
with anti-MBP antibodies and was used as a loading control. 
Fig. 2. Overexpression of LptE suppresses the drug sensitivity of the ΔbepA strain. (A) 
Erythromycin sensitivity of the ΔbepA strain transformed with an ASKA clone carrying lptE. 
pCA24NΔNot was used as a vector control. For comparison, the MIC of the ΔbepA strain 
transformed with pTH-bepA-his10 encoding wild-type BepAHis10 is shown. (B) LptE was 
overexpressed from pMAN-lptE carrying lptE under the control of the araBAD promoter. 
Expression of LptE was confirmed by SDS-PAGE of total cellular proteins followed by 
anti-LptE immunoblotting. 
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Fig. 3. Defective oxidative folding of LptD in the absence of BepA. (A) Immunoblotting of 
LptD was carried out after reducing (+ME) or nonreducing (-ME) SDS-PAGE of total cellular 
proteins. Wild-type (+) or ΔbepA (-) cells were grown overnight at 30°C. Anti-LptE 
immunoblotting was also carried out after reducing SDS-PAGE. The positions of reduced LptD 
(LptDRED), properly oxidized LptD (LptDNC), rapidly migrating LptD (LptDC), LptE, and 
molecular weight markers are indicated. (B) Schematic representation of disulfide bonds in 
LptDNC and LptDC. Asterisk indicates a nonspecific band. 
Fig. 4. BepA facilitates disulfide isomerization in LptD. (A) Wild-type and ΔbepA cells were 
labeled with [35S]-methionine for 1 min and chased for the indicated durations at 30°C. 
Acid-precipitated proteins were subjected to immunoprecipitation with anti-LptD antiserum and 
were analyzed by nonreducing (-ME) or reducing (+ME) SDS-PAGE followed by 
phosphorimaging. Migration positions of molecular weight markers are shown on the left. (B) 
Oxidative folding of LptD was monitored as in (A) using ΔbepA cells transformed with empty 
vector or either of the plasmids encoding C-terminally His10-tagged wild-type BepA or its 
H136R or E137Q derivative. LptDNC (%) in the right panels was calculated by dividing the band 
intensity of LptDNC by the sum of those of LptDC and LptDNC. 
Fig. 5. BepA destabilizes LptD in LptE-limiting conditions. (A) LptE-depleted cells carrying 
bepA (bepA+) or its disruptant were pulse-labeled and analyzed as described in the legend to Fig. 
4A. (B and C) The stability of LptD was assessed as in (A) using the ΔbepA (B) or wild-type (C) 
cells transformed with empty vector or either of the plasmids encoding C-terminally 
His10-tagged wild-type BepA or its H136R or E137Q derivative. 
Fig. 6. bamB/bepA and bamE/bepA double disruptants show elevated drug sensitivity. (A) MICs 
of erythromycin (ERM), rifampicin (RIF), vancomycin (VCN), and novobiocin (NOV) at 30°C 
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for strains lacking bepA, bamB, bamC, and bamE individually or in combinations as indicated. 
(B) Overnight cultures of strains lacking bepA, bamB, bamC, and bamE individually or in 
combinations as indicated were serially diluted with saline, spotted onto L agar with or without 
0.5% SDS, and incubated at 30°C for 24 h. (C) bamB/bepA and bamE/bepA double-knockout 
strains were transformed with a plasmid encoding wild-type BepA or its H136R or E137Q 
derivative and were grown on L agar containing 0.5% SDS for 24 h at 30°C or 37°C. 
Fig. 7. BepA interacts with the BAM complex. (A-G) BS3-mediated cross-linking. (A and B) 
Wild-type cells transformed with the pUC18 vector (-) or its derivative encoding the 
C-terminally His10-tagged wild-type BepA (WT) or its H136R or E137Q derivative were 
subjected to cross-linking with BS3 as described in the Materials and Methods section. 
Membrane (M) and periplasmic (P) fractions were analyzed to SDS-PAGE followed by 
immunoblotting with anti-BepA (A) or anti-BamA (B) antisera. The cross-linked product of 
BepA and BamA is indicated (× BamA; also indicated by asterisks). (C–G) The ΔbepA strain 
(WT) or the ΔbepA strain also having deletions of bamB (ΔB), bamC (ΔC), or bamE (ΔE) were 
transformed with empty vector (-) or a plasmid encoding tag-free BepA(E137Q) and were 
subjected to BS3 cross-linking. Membrane fractions were analyzed by WIDE RANGE PAGE	 
(Nacalai Tesque, Kyoto, Japan) (7.5% acrylamide), except for (D), in which normal SDS-PAGE 
was employed, followed by immunoblotting with anti-BepA (C), anti-BamA (D), anti-BamB 
(E), anti-BamC (F), or anti-BamD (G) antisera. (H) Photo-crosslinking of BepA and BamA. 
The ΔbepA cells transformed with pEVOL-pBpF (aminoacyl-tRNA synthetase/suppressor 
tRNA) and the plasmid encoding a BepA derivative with an amber codon at position 428 were 
grown with or without pBPA and were UV-irradiated for 10 min. Acid precipitated proteins 
were analyzed by SDS-PAGE and immunoblotting with anti-BepA and anti-BamA antisera. 
The cross-linked product between BepA(Q428pBPA) and BamA is indicated. (I) Pull-down 
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assay. Wild-type strain (WT) transformed with empty vector or the ΔbamB strain transformed 
with a plasmid encoding C-terminally His6-tagged BamB (BamBHis6) were co-transformed with 
a plasmid encoding BepA(E137Q). Membrane proteins were solubilized and subjected to a 
pull-down assay using His6 tag of BamB. Solubilized membrane (input) and affinity-purified 
proteins (eluate, a fivefold equivalent for Bam component immunoblotting and a 50-fold 
equivalent for BepA and OmpA immunoblotting) were analyzed by SDS-PAGE and 
immunoblotting. 
Fig. 8. BepA-dependent degradation of BamA in the ΔsurA strain. Total cellular protein was 
prepared from wild-type or mutant cells lacking bepA and/or surA (lanes 1–4) or ΔsurA/ΔbepA 
cells harboring empty vector or either of the plasmids encoding C-terminally His10-tagged 
wild-type BepA or its H136R or E137Q derivative (lanes 5–8) and was subjected to SDS-PAGE 
followed by immunoblotting with anti-BamA or anti-BepA antisera. Putative BepA degradation 
products of BamA are indicated by asterisks. 
Fig. 9. A model for BepA function in the assembly/degradation of the OM LPS translocon. 
(upper panel) BepA promotes disulfide rearrangement of LptDC that is triggered by association 
of LptDC with LptE. BepA may directly assist LptD-LptE interaction or act indirectly to 
facilitate formation of the productive LptD-LptE complex. Square brackets represent disulfide 
bonds (lower panel). In the absence of LptE, BepA acts to proteolytically eliminate accumulated 
LptDC. 
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Supporting Information 
SI Materials and Methods 
Bacterial strains 
SN1145 was constructed by removing the kanamycin-resistance cassette from GC187 by using 
pCP20. Gene disruption of AD16, MC4100, and SN1145 was conducted by transferring the 
kanamycin-resistance cassette from a corresponding strain of the Keio collection by 
P1-mediated transduction (1). Multiple-gene disruptants were constructed by successive 
transduction combined with removal of the kanamycin-resistance cassette by using pCP20 as 
described previously (2). SN147, SN150, and SN909 were constructed by transducing the 
ΔbamB::tet allele from SM4106 to AD16, SN56, and SN896, respectively, by P1 transduction. 
All gene disruptions were verified by PCR with appropriate primers. 
Plasmids 
For construction of pCA24NΔNot, which was used as an empty vector control for ASKA 
plasmids, a NotI fragment was deleted from pCA24N (3) by digestion with NotI followed by 
self-ligation. pUC-bepA-his6 was constructed as follows. A DNA fragment encoding BepAHis6 
was amplified by PCR from the genomic DNA of E. coli BW25113 (4) using a pair of primers, 
yfgC-1 and yfgC-2 (Supplemental Table S3). The amplified DNA fragment was digested with 
EcoRI and KpnI and then cloned into the same sites of pUC18. pTTQ-bepA-his6 was 
constructed essentially as described for pUC-bepA-his6 except that the DNA fragment was 
amplified with yfgC-3 instead of yfgC-1 and cloned into pTTQ18. pUC-bepA-his10 was 
constructed by self-ligation of a DNA fragment that was PCR-amplified from pUC-bepA-his6 
using a pair of primes, yfgC-his10-1 and yfgC-his10-2, after treatment with T4 polynucleotide 
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kinase (TaKaRa Bio, Otsu, Japan). pTH-bepA-his10 was constructed by subcloning the 
EcoRI-SalI fragment derived from pUC-bepA-his10 into the same sites of pTH18cr. For 
construction of pCDF-bepA-his10, a DNA fragment was PCR-amplified from pUC-bepA-his10 
using a pair of primers, yfgC-4 and M4C, digested with NcoI and SalI, and cloned into the same 
sites of pCDFDuet-1. For construction of pUC-bepA, a DNA fragment was PCR-amplified 
from pTH-bepA-his10 using a pair of primers, yfgC-1 and yfgC-Pst-2, and cloned into the 
EcoRI-SmaI site of pUC18 after digestion with EcoRI. Plasmids encoding the H136R mutant 
form of BepA were constructed by site-directed mutagenesis using a pair of complementary 
primers, yfgC_H136R and yfgC_H136R-r. Plasmids encoding the E137Q mutant form of BepA 
were constructed in the same way using primers yfgC_E137X and yfgC_E137X-r. 
pUC-bepA(Q428Amber) was also constructed in the same way using primers TPR4-2 and 
TPR4-2-r. pMAN-lptE was constructed as follows. The lptE coding region was PCR-amplified 
from the genomic DNA of BW25113 using a pair of primers, lptE-1 and lptE-2. The amplified 
DNA fragment was digested with EcoRI and HindIII, and then cloned into the same sites of 
pMAN885EH. To construct pMAN-lptD-his6, a DNA fragment encoding LptDHis6 was 
amplified by PCR from the genomic DNA of BW25113 using a pair of primers, lptD-1 and 
lptD-2, digested with XbaI, and cloned into the SmaI-XbaI site of pMAN885EH. 
pMAN-lptD-his6 derivatives encoding LptDHis6 with Cys to Ser substitutions were constructed 
by site-directed mutagenesis. To construct pMAN-bamB-his6, a DNA fragment encoding 
BamBHis6 was amplified by PCR from the genomic DNA of DH5α using a pair of primers, 
yfgL-1 and yfgL-2, digested with EcoRI and HindIII, and cloned into the same sites of 
pMAN885EH. 
Purification of BepA and in vitro proteolytic activity assay 
KRX cells were transformed with pCDF-bepA-his10 or pCDF-bepA(E137Q)-his10 encoding 
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His10-tagged wild-type BepA or BepA(E137Q) and grown in L medium supplemented with 
0.1% rhamnose at 37°C. When the culture OD (at 600 nm) reached 1.0, cells were harvested by 
centrifugation at 5,000 × g for 10 min, and then resuspended in 20 mM Tris–HCl (pH 7.5) 
containing 1 µg/mL DNase I. Cells were disrupted by a single passage through a French Press 
cell at 10,000 psi. After removal of unbroken cells by centrifugation at 10,000 × g for 5 min, 
membranes were removed by centrifugation at 100,000 × g for 1 h. The supernatant was applied 
to TALON metal affinity resin (Clontech), and the column was successively washed with buffer 
A (20 mM Tris–HCl (pH 7.5), 50 mM NaCl) supplemented with 0, 5, or 20 mM imidazole, and 
finally eluted with buffer A containing 50 mM imidazole.  
 For protease activity assay, a purified preparation of BepAHis10 or BepA(E137Q)His10 
(200 µg/mL) was mixed with α-casein (400 µg/mL; Sigma) and incubated at 37°C in buffer 
containing 20 mM Tris-HCl (pH 7.5), 0.05% n-dodecyl-β-D-maltopyranoside (DDM), and 10 
µM ZnCl2. Where specified, 1,10-phenanthroline or EDTA instead of ZnCl2 was added at 250 
µM. Samples were mixed with a quarter volume of 5× SDS sample buffer, boiled for 5 min, and 
subjected to SDS-PAGE. Proteins were visualized by staining with Coomassie brilliant blue 
R-250 (CBB). 
Pull-down assay 
Cells of AD16 transformed with pMAN885EH and pUC-bepA(E137Q), and SN147 
transformed with pMAN-bamB-his6 and pUC-bepA(E137Q), were grown in L medium 
supplemented with 0.01% arabinose and 0.1 mM IPTG at 30°C. When the culture OD reached 
1.0, cells were harvested by centrifugation at 5,000 × g for 10 min, and resuspended in 20 mM 
Tris–HCl (pH 7.5) containing 1 µg/mL DNase I. Cells were disrupted by a single passage 
through a French Press cell at 10,000 psi. After removal of unbroken cells by centrifugation at 
10,000 × g for 5 min, the membrane fraction was recovered by centrifugation at 100,000 × g for 
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1 h. The membranes were resuspended in 20 mM Tris-HCl (pH 7.5) containing 300 mM NaCl 
and 2% (w/v) DDM, and incubated at 4°C for 30 min for solubilization. After removal of 
insoluble materials by centrifugation at 100,000 × g for 30 min, the supernatant was diluted 10 
fold with 20 mM Tris-HCl (pH 7.5) containing 300 mM NaCl and applied to Dynabeads His-tag 
Isolation & Pulldown (Invitrogen). The beads were successively washed with buffer B (20 mM 
Tris–HCl (pH 7.5), 300 mM NaCl, 0.05% DDM), supplemented with 0, 5, 20, or 50 mM 
imidazole, and eluted with buffer B containing 250 mM imidazole. 
Mass spectrometry 
The membrane fraction of bis(sulfosuccinimidyl) suberate (BS3)-treated spheroplasts of 
MC4100 transformed with pTTQ-bepA(E137Q)-his6 was prepared as described above and 
solubilized in 50 mM Tris-HCl (pH 7.5) containing 0.5% SDS at 37°C for 5 min. After 10-fold 
dilution with 20 mM Tris-HCl (pH 7.5) containing 2% Triton X-100, insoluble materials were 
removed by ultracentrifugation at 100,000 × g for 30 min, and the supernatant was mixed with 
Ni-NTA agarose resin (Qiagen) for 1 h at 4°C. Resin was washed with 20 mM Tris-HCl (pH 
7.5) containing 300 mM NaCl, 0.2% (w/v) Triton X-100, and either 0, 5, or 20 mM imidazole, 
and bound BepAHis6 was eluted with 20 mM Tris-HCl (pH 7.5) containing 300 mM NaCl and 
250 mM imidazole. The cross-linked product containing BepA was visualized by staining with 
CBB after SDS-PAGE. An excised CBB-stained gel band was destained with 50% (v/v) 
acetonitrile in 10 mM Tris-HCl (pH 8.0) and then dried in vacuo. The band was incubated with 
0.01 µg trypsin, TPCK-treated (Worthington Biochemical Corporation, Lakewood, NJ) in 10 
mM Tris-HCl (pH 8.0) at 37°C for 12 h. An aliquot of the digest was analyzed by nano 
LC-MS/MS using an LCQ Deca XP instrument (Thermo Fisher Scientific). The peptides were 
separated using a nano ESI spray column (100 µm i.d. × 375 µm o.d.) packed with a 
reversed-phase material (Inertsil ODS-3, 3 µm, GL Science, Tokyo, Japan) at a flow rate of 200 
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nL/min. The mass spectrometer was operated in the positive-ion mode, and the spectra were 
acquired in a data-dependent MS/MS mode. The MS/MS spectra were searched against the 
NCBInr 20111107 database (15,916,306 sequences; 5,467,648,827 residues) using an in-house 
MASCOT server (version: 2.2.1, Matrix Science, London, UK). 
Alkylation of LptDHis6 
Cells of AD16 transformed with pMAN885EH derivatives encoding wild-type LptDHis6, 
LptD(SSCC)His6, or LptD(CCSS)His6 were grown overnight in L medium at 30°C. They were 
harvested, resuspended in 100 mM Tris-HCl (pH 8.0), and incubated in the absence or presence 
of 100 mM DTT at room temperature for 30 min. Total cellular proteins were precipitated by 
trichloroacetic acid treatment and solubilized with 100 mM Tris-HCl (pH 8.0) containing 1% 
SDS by vortexing at room temperature for 30 min. Samples were incubated in the absence or 
presence of 10 mM EZ-Link Maleinide-PEG2-Biotin (Thermo Fisher Scientific) at 37°C for 30 
min. Proteins were separated by SDS-PAGE, and LptDHis6 was detected by immunoblotting 
with anti-His antibodies. 
Cell fractionation 
Subcellular localization of LptD was determined as follows. Cells of AD16 and SN56 (ΔbepA) 
were grown overnight in L medium at 30°C. They were harvested, resuspended in 20 mM 
Tris-HCl (pH 7.5) containing 1 mM Pefabloc (Merck) and 100 µg/mL lysozyme, and subjected 
to freezing and thawing. Then, 10 µg/mL DNase I was added to the samples, and cells were 
disrupted by sonication. After removal of unbroken cells, membranes were recovered by 
centrifugation at 100,000 × g for 1 h at 4°C and suspended in 20 mM Tris-HCl (pH 7.5) 
containing 1 mM EDTA and 1 mM Pefabloc. The supernatant was saved as the soluble fraction. 
Total membranes thus obtained were layered on a 30–55% (w/w) stepwise sucrose gradient and 
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centrifuged at 60,000 × g for 12 h at 4°C. The sucrose gradient was fractionated into portions 
and analyzed by SDS-PAGE and immunoblotting. 
Growth of LptE-deficient strains 
Cells of GC187 and their derivatives were grown overnight in M9 medium supplemented with 
19 amino acids other than methionine, 2 µg/mL thiamine, 0.2% arabinose, and 0.2% glucose or 
maltose. Cells from 1-mL aliquots cultures were pelleted, washed three times with equal 
volumes of the same medium without arabinose, and inoculated into the same medium without 
arabinose to an initial OD600 of ~0.001. Cells were subsequently grown at 30°C to an early log 
phase. 
Other techniques 
The minimum inhibitory concentrations (MICs) of antibiotics were determined by the agar 
dilution method using L agar. SDS-PAGE was carried out as described (5), unless otherwise 
specified. WIDE RANGE Gel Preparation buffer (Nacalai Tesque, Kyoto, Japan) was used in 
some experiments to improve separation of proteins. To raise anti-BepA antibodies, BepAHis6 
was purified from SN150 carrying pTTQ-bepA-his6 by metal affinity chromatography using 
TALON resin (Clontech) and used to immunize rabbits. A Penta-His HRP Conjugate Kit 
(Qiagen) or anti-His-tag polyclonal antibodies (MBL, Nagoya, Japan) were used to probe 
polyhistidine-tagged proteins. Anti-BamA, -BamB, -BamD, -LptD, and -LptE antisera were 
provided by Dr. Shin-ichi Matsuyama (Rikkyo University). Anti-BamC and -LamB antisera 
were provided by Dr. Thomas J. Silhavy (Princeton University). Anti-OmpA antiserum was 
provided by Dr. Hajime Tokuda (University of Morioka). Anti-MBP antiserum was purchased 
from MBL. Immunoblotting was carried out essentially as described previously (6), and 
proteins were visualized using enhanced chemiluminescence substrate (ECL or ECL Prime; GE 
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Healthcare), followed by detection with a lumino-image analyzer (LAS-3000mini; Fujifilm). 
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Legends to SI Figures 
Fig. S1. Membrane protein profiles of the wild-type and ΔbcpA strains. Crude membranes 
prepared from overnight cultures of wild-type (+) or ΔbcpA cells (-) were solubilized in a 
SDS-PAGE sample buffer with (+) or without (-) heating at 99°C for 5 min and were analyzed 
by the WIDE RANGE PAGE (10% acrylamide) followed by CBB staining. 
Fig. S2. Connectivity of disulfide bonds and subcellular localization of LptDC. (A) Cells of 
wild-type or ΔbepA strains were transformed with plasmids encoding C-terminally His6-tagged 
LptD (LptDHis6) with Cys to Ser substitutions. Total cellular proteins were acid precipitated and 
analyzed by nonreducing (-ME) or reducing (+ME) SDS-PAGE and immunoblotting with 
anti-His-tag antibodies. Asterisks indicate LptDHis6 with a disulfide bond of C31-C724 (*), 
C173-C724 or C173-C725 (**), or C724-C725 (***), while bullets indicate a degradation product of 
LptDHis6. (B) Sulfhydryl modification. Wild-type cells transformed with a plasmid encoding 
wild-type LptDHis6 (denoted as CCCC) or LptDHis6 with C31S/C173S substitutions (SSCC) or 
C724S/C725S substitutions (CCSS) were incubated in the presence or absence of DTT. 
Acid-denatured cellular proteins were labeled with maleimide-PEG2-biotin (MB), and analyzed 
by reducing SDS-PAGE followed by immunoblotting with anti-His antibodies. (C) Subcellular 
localization of LptDC. Wild-type (+) or ΔbepA (-) cells were fractionated into membrane (M) 
and soluble (S) fractions. Anti-LptD, anti-MBP, or anti-FtsH immunoblotting was carried out 
after nonreducing SDS-PAGE. FtsH (7) and MBP were detected as markers for membrane and 
soluble fractions, respectively. (D) Membranes of ΔbepA cells were fractionated into the IM and 
OM by sucrose gradient centrifugation. Proteins of each fraction were analyzed by nonreducing 
SDS-PAGE and immunoblotting with anti-LptD antiserum. FtsH was used as a marker for the 
IM. 
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Fig. S3. Dominant-negative effect of the BepA protease active-site mutants on disulfide 
isomerization of LptD. Oxidative folding of LptD was monitored using wild-type cells 
transformed with either of the plasmids encoding C-terminally His10-tagged wild-type BepA or 
its H136R or E137Q derivative. 
Fig. S4. Overexpression of LptE facilitates disulfide isomerization in LptD. (A) Immunoblotting 
analysis. ΔbepA cells were transformed with an empty vector or pMAN-lptE carrying lptE 
under the control of the araBAD promoter and grown in the absence (-) or presence (+) of 0.2% 
arabinose. Immunoblotting of LptD was carried out after nonreducing SDS-PAGE of total 
cellular proteins. (B) Pulse-chase analysis. Oxidative folding of LptD was monitored as in Fig. 4 
using ΔbepA cells transformed with an empty vector or pMAN-lptE grown in M9 medium 
supplemented with 0.2% glucose (- ara) or 0.2% maltose plus 0.2% arabinose (+ ara).  
Fig. S5. Disulfide isomerization of LptD in the cells lacking periplasmic oxidoreductases. (A) 
Effects of the dsbC and dsbD disruption. Oxidative folding of LptD was monitored as in Fig. 4 
using dsbC and/or dsbG knockout cells carrying wild-type bepA or its disruptant. (B) Effects of 
the dsbA disruption. dsbA knockout cells additionally lacking dsbC, dsbG, and/or bepA as 
indicated were analyzed as in (A) with nonreducing (-ME) or reducing (+ME) SDS-PAGE. 
Fig. S6. Subcellular localization of BepA. Wild-type (+) or ΔbepA (-) cells were disrupted by 
sonication and fractionated into membrane (M) and soluble (S) fractions by ultracentrifugation. 
Each protein was detected by SDS-PAGE and immunoblotting with antiserum against 
respective proteins. 
Fig. S7. Purification of the BS3-mediated cross-linked product. Spheroplasts of wild-type cells 
transformed with a plasmid encoding C-terminally His6-tagged BepA with E137Q substitution 
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were treated with BS3. BepA(E137Q)His6 and its cross-linked products were affinity purified as 
described in the Materials and Methods section and visualized by staining with CBB after 
SDS-PAGE. The cross-linked product (× BamA) that was subsequently identified as the 
BamA-BepA adduct by mass spectrometry is indicated. 
Fig. S8. Effect of the surA disruption or BepA overproduction on the OM protein profiles. (A 
and B) Effect on LamB and OmpA. Total cellular protein was prepared from ΔsurA/ΔbepA cells 
harboring empty vector or either of the plasmids encoding C-terminally His10-tagged wild-type 
BepA or its H136R or E137Q derivative and was subjected to SDS-PAGE followed by 
immunoblotting with anti-LamB (A) or anti-OmpA (B) antisera. (C) Effect on BamA. 
Overexpression of BepA does not cause the degradation of BamA in the surA+ cells. Total 
cellular proteins were prepared from wild-type (lanes 1, 3-6) or the ΔsurA cells (lane 2) without 
plasmid (lanes 1 and 2) or with either empty vector or a plasmid encoding C-terminally 
His10-tagged wild-type BepA or its H136R or E137Q derivative (lanes 3–6) and was subjected 
to SDS-PAGE followed by immunoblotting with anti-BamA or anti-BepA antisera. Putative 
BepA degradation products of BamA are indicated by asterisks. 
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Table S1. List of ASKA plasmids that suppressed erythromycin sensitivity of the ΔbepA ΔbamE 
strain. 
Plasmida Gene Product Growth  
on SDSb 
MIC of (µg/ml) 
Erythromycin Vancomycin 
   - IPTG + IPTG - IPTG + IPTG 
pTH-bepA-his10 BepA + 12.5 25 50 100 
pCA24NΔNot empty vector - 6.25 3.13 25 25 
fhuF ferric iron reductase + 25 12.5 25 50 
mppA murein tripeptide transporter + 6.25 12.5 25 50 
stfQ predicted side tail fibre assembly protein + 6.25 12.5 25 50 
yaiU conserved protein + 6.25 12.5 25 50 
ydfW pseudogene, integrase fragment, Qin prophage + 25 25 25 50 
yeaH conserved protein + 6.25 12.5 25 25 
ychP predicted invasin + 6.25 12.5 25 50 
yneO AidA homolog, autotransporter + 6.25 12.5 25 25 
ynjE predicted thiosulfate sulfur transferase + 6.25 12.5 25 50 
appY global transcription regulator + 6.25 12.5 25 25 
gadW transcriptional activator of gadA and gadBC + 6.25 12.5 25 50 
soxS DNA-binding transcriptional dual regulator + 6.25 12.5 25 25 
ydeO transcriptional activator for mdtEF + 6.25 25 25 50 
rluE 23S rRNA U2457 pseudouridine synthase + 6.25 12.5 25 25 
lptE LPS assembly OM complex ± 12.5 12.5 50 50 
pagP palmitoyl transferase for Lipid A ± 6.25 12.5 25 50 
ybiI DksA-type zinc finger protein ± 6.25 6.25 25 25 
bcsC cellulose synthase subunit ± 6.25 12.5 25 25 
rrmJ 23S rRNA U2552 ribose 2'-O-methyltransferase ± 6.25 12.5 12.5 25 
rplO 50S ribosomal subunit protein L15 - 6.25 6.25 25 25 
rpsM 30S ribosomal subunit protein S13 - 6.25 6.25 25 25 
ykgO predicted ribosomal protein - 6.25 6.25 25 25 
marA transcriptional activator of multiple antibiotic resistance - 6.25 6.25 12.5 6.25 
yaiT conserved protein - 6.25 12.5 25 50 
yhfG predicted protein - 6.25 6.25 12.5 25 
 +, normal growth; ±, weak growth; −, no growth. 
aCloned genes in ASKA plasmids are shown.  
bGrowth phenotype on L agar containing 0.5% SDS is shown. 
Table S2. Strains used in this study. 
E. coli strains Genotype Reference 
AD16 Δpro-lac thi [F’ lacIq ZM15 Y+ pro+]    1 
SN56 AD16 ΔbepA This study 
SN147 AD16 ΔbamB::tet This study 
SN150 AD16 ΔbamB::tet ΔbepA This study 
SN305 AD16 ΔsurA::kan This study 
SN259 AD16 ΔsurA::kan ΔbepA This study 
SN531 AD16 ΔbamC::kan This study 
SN533 AD16 ΔbamC::kan ΔbepA This study 
SN535 AD16 ΔbamE::kan This study 
SN537 AD16 ΔbamE::kan ΔbepA This study 
SN547 AD16 ΔdsbA::kan This study 
SN548 AD16 ΔdsbA::kan ΔbepA This study 
 SN807 AD16 ΔdsbC This study 
SN773 AD16 ΔdsbC ΔbepA This study 
SN834 AD16 ΔdsbC ΔdsbG This study 
SN835 AD16 ΔdsbC ΔdsbG ΔbepA This study 
SN836 AD16 ΔdsbA::kan ΔdsbC ΔdsbG This study 
SN838 AD16 ΔdsbA::kan ΔdsbC ΔdsbG ΔbepA This study 
MC4100 araD139 Δ(argF-lac)U169 rpsL150 relA1 flbB5301 
deoC1 ptsF25 rbsR 
   2   
SN896 MC4 00 ΔbepA This study 
SN909 MC4100 ΔbamB::tet ΔbepA This study 
SN910 MC4100 ΔbamC::kan ΔbepA This study 
SN911 MC4100 ΔbamE::kan ΔbepA This study 
AM604 MC4100 ara+    3 
GC187 AM604 ΔlptE2::kan Δ(λatt-lom)::bla-ParalptE(atg)-araC Gift from T. Silhavy 
SN1145 GC187 KmS This study 
SN1159 SN1145 ΔbepA::kan This study 
SN1194 SN1145 ΔbepA This study 
KRX ∆pro-lac thi [F’ traD36 ∆ompP lacIq ZM15 pro+] 
∆ompT endA1 recA1 gyrA96 hsdR17 e14- relA1 supE44 
∆rhaBAD::T7 RNA polymerase 
Promega 
   
 
1. Kihara A, Akiyama Y, Ito K (1996) A protease complex in the Escherichia coli plasma membrane: HflKC (HflA) forms a 
complex with FtsH (HflB), regulating its proteolytic activity against SecY. EMBO J 15(22): 6122–6131. 
2. Casadaban MJ (1976) Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage 
lambda and Mu. J Mol Biol 104(3): 541-555. 
3. Wu T, et al. (2006) Identification of a protein complex that assembles lipopolysaccharide in the outer membrane of 
Escherichia coli. Proc Natl Acad Sci USA 103(31): 11754-11759. 
 
 
 
 
 
 
 
 
 
 
  
Table S3. Plasmids used in this study. 
1. Cherepanov PP, Wackernagel W (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of 
Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158(1):9–14. 
2. Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of 
the M13mp18 and pUC19 vectors. Gene 33(1):103–119.  
3. Stark MJ (1987) Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in 
Escherichia coli. Gene 51(2-3):255–267.  
4. Hashimoto-Gotoh T, et al. (2000) A set of temperature sensitive-replication/-segregation and temperature resistant plasmid 
vectors with different copy numbers and in an isogenic background (chloramphenicol, kanamycin, lacZ, repA, par, polA). 
Gene 241(1):185–191.  
5. Young TS, Ahmad I, Yin JA, Schultz PG (2010) An enhanced system for unnatural amino acid mutagenesis in E. coli. J Mol 
Biol 395(2):361–374.  
6. Yakushi T, Tajima T, Matsuyama S, Tokuda H (1997) Lethality of the covalent linkage between mislocalized major outer 
membrane lipoprotein and the peptidoglycan of Escherichia coli. J Bacteriol 179(9):2857–2862. 
Plasmids Description Reference 
pCA24NΔNot Expression vector for ASKA clones; PT5-lac cat This study 
pCP20 pSC101 derivative; Rep(Ts) bla cat λcI857 λPR FLP+    1 
pUC18 Expression vector; Plac bla    2    
pUC-bepA pUC18 derivative encoding BepA This study 
pUC-bepA(H136R) pUC18 derivative encoding BepA(H136R) This study 
pUC-bepA(E137Q) pUC18 derivative encoding BepA(E137Q) This study 
pUC-BepA(Q428Amber) pUC18 derivative encoding BepA(Q428Amber) This study 
pUC-bepA-his6 pUC18 derivative encoding BepAHis6 This study 
pUC-bepA-his10 pUC18 derivative encoding BepAHis10 This study 
pUC-bepA(H136R)-his10 pUC18 derivative encoding BepA(H136R)His10 This study 
pUC-bepA(E137Q)-his10 pUC18 derivative encoding BepA(E137Q)His10 This study 
pTTQ18 Expression vector; Ptac bla    3 
pTTQ-bepA-his6 pTTQ18 derivative encoding BepAHis6 This study 
pTTQ-bepA(E137Q)-his6 pTTQ18 derivative encoding BepA(E137Q)His6 This study 
pTH18cr Expression vector; Plac cat    4 
pTH-bepA-his10 pTH18cr derivative encoding BepAHis10 This study 
pTH-bepA(H136R)-his10 pTH18cr derivative encoding BepA(H136R)His10 This study 
pTH-bepA(E137Q)-his10 pTH18cr derivative encoding BepA(E137Q)His10 This study 
pCDFDuet-1 Expression vector; PT7 aadA Novagen 
pCDF-bepA-his10 pCDFDuet-1 derivative encoding BepAHis10 This study 
pCDF-bepA(E137Q)-his10 pCDFDuet-1 derivative encoding BepA(E137Q)His10 This study 
pEVOL-pBpF p15A derivative encoding an evolved M. jannaschii    5 
  aminoacyl-tRNA synthetase/suppressor tRNA pair for  
  incorporation of pBPA at the amber site  
pMAN885EH Expression vector, PBAD cat    6 
pMAN-lptD-his6 pMAN885EH derivative encoding LptDHis This study 
pMAN-lptD(C31S)-his6 pMAN885EH derivative encoding LptD(SCCC)His6 This study 
pMAN-lptD(C173S)-his6 pMAN885EH derivative encoding LptD(CSCC)His6 This study 
pMAN-lptD(C724S)-his6 pMAN885EH derivative encoding LptD(CCSC)His6 This study 
pMAN-lptD(C725S)-his6 pMAN885EH derivative encoding LptD(CCCS)His6 This study 
pMAN-lptD(C31S/C173S)-his6 pMAN885EH derivative encoding LptD(SSCC)His6 This study 
pMAN-lptD(C724S/C725S)-his6 pMAN885EH derivative encoding LptD(CCSS)His6 This study 
pMAN-lptE pMAN885EH derivative encoding LptE This study 
pMAN-bamB-his6 
 
pMAN885EH derivative encoding BamBHis6 This study 
 
 
aq 
 
Table S4. Primers used in this study. 
Name Sequencea (5' - 3') 
yfgC-1 GATGAATTCCAGAAATACAGGATAGAG 
yfgC-2 GGGGTACCTAATGATGATGATGATGATGCTCGAGCATCTTGGTATAAGGCTTAAAG 
yfgC-3 ATGAATTCCAGGCAGTTGAAAAAAAACC 
yfgC-4 CATGCCATGGTCAGGCAGTTGAAAAAAAACCTGG 
M13 Primer M4 GTTTTCCCAGTCACGAC 
yfgC-his10-1 CATCATCATCATTAAGTACCCG 
yfgC-his10-2 ATGATGATGATGATGATGCTCG 
yfgC_PstI-2 TTACATCTTGGTATAAGGCTTAAAGCGTTCCTGCA 
yfgC_H136R CTGGCTTCAGTTATGGCGCGCGAAATCTCCCACGTCACC 
yfgC_H136R-r GGTGACGTGGGAGATTTCGCGCGCCATAACTGAAGCCAG 
yfgC_E137X GGCTTCAGTTATGGCGCACYAGATCTCCCACGTCACCCAACG 
yfgC_E137X-r CGTTGGGTGACGTGGGAGATCTRGTGCGCCATAACTGAAGCC 
TPR4-2 GCTAAATAACCGCGATTAGGAGCTGGCTGCGCG 
TPR4-2-r CGCGCAGCCAGCTCCTAATCGCGGTTATTTAGC 
lptE-1 GATGAATTCTGGTCGTTGGCTAAGCGC 
lptE-2 CAATTCAAGCTTCATTGAGCTGCGCGCGG 
lptD-1 AACGTTACCGATGATGGAAC 
lptD-2 CAATTCTCTAGATTAGTGATGGTGATGGTGATGCTCCAAAGTGTTTTGATACGGCAG 
lptD_C31S GCCGACCTCGCCTCACAGTCAATGTTGGGCGTGCCAAGC 
lptD_C31S-r GCTTGGCACGCCCAACATTGACTGTGAGGCGAGGTCGGC 
lptD_C173S CGGTAGCTTTACCTCCTCACTGCCGGGTTCTGACACCTG 
lptD_C173S-r CAGGTGTCAGAACCCGGCAGTGAGGAGGTAAAGCTACCG 
lptD_C724S GCAATACAGCTCCTCATGCTATGCAATTCGC 
lptD_C724S-r GCGAATTGCATAGCATGAGGAGCTGTATTGC 
lptD_C725S GTGCAATACAGCTCCTGCTCATATGCAATTCGCGTCGGTTAC 
lptD_C725S-r GTAACCGACGCGAATTGCATATGAGCAGGAGCTGTATTGCAC 
lptD_C724S/C725S GTGCAATACAGCTCCTCATCATATGCAATTCGCGTCGGTTAC 
lptD_C724S/C725S-r GTAACCGACGCGAATTGCATATGATGAGGAGCTGTATTGCAC 
yfgL-1 GATGAATTCGGAGGTTTAAATTTATGCAATTGCGTAAATTACTGC 
yfgL-2 CAATTCAAGCTTAGTGATGGTGATGGTGATGCTCCAGACGTGTAATAGAGTACACGGTTC 
aThe following IUB codes are used to indicate base mixtures: Y= C+T; R=A+G 
